The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.
Ye, the provocative rapper formerly known as Kanye West, explains himself once again — this time in a full-page ad in Monday’s issue of the Wall Street Journal.